KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $184.7 million.

  • BioNTech SE's Other Non-Current Liabilities rose 1227.71% to $184.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.7 million, marking a year-over-year increase of 1227.71%. This contributed to the annual value of $181.0 million for FY2024, which is 3448.73% up from last year.
  • BioNTech SE's Other Non-Current Liabilities amounted to $184.7 million in Q3 2025, which was up 1227.71% from $179.5 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Other Non-Current Liabilities ranged from a high of $878.2 million in Q4 2022 and a low of $6.8 million during Q1 2021
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $179.5 million (2025), whereas its average is $275.7 million.
  • In the last 5 years, BioNTech SE's Other Non-Current Liabilities soared by 553584.51% in 2022 and then plummeted by 8467.37% in 2023.
  • Quarter analysis of 5 years shows BioNTech SE's Other Non-Current Liabilities stood at $52.7 million in 2021, then soared by 1565.3% to $878.2 million in 2022, then tumbled by 84.67% to $134.6 million in 2023, then skyrocketed by 34.49% to $181.0 million in 2024, then rose by 2.04% to $184.7 million in 2025.
  • Its last three reported values are $184.7 million in Q3 2025, $179.5 million for Q2 2025, and $178.8 million during Q1 2025.